Stock ARDS ARIDIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Aridis Pharmaceuticals, Inc.

Equities

ARDS

US0403341045

Market Closed - OTC Markets
Other stock markets
 20:39:49 01/05/2024 BST 		5-day change 1st Jan Change
0.0588 USD -2.08% Intraday chart for Aridis Pharmaceuticals, Inc. -7.40% -16.12%
2023 Aridis Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Certain Options of Aridis Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 16-SEP-2023. CI

Chart calendar Aridis Pharmaceuticals, Inc.

52462.BJqowVBcFLo6z26yC2g-5WLIvCtAvWEc_WU5_ah6y68.YtjZgwo5QI8OoTzmRAAOpDaHyWoY5REuhUhWueIIkvV2yp31HBNhiGCsVg~32dbfd91b284d0b4814d954eb1265b0d

Upcoming events on Aridis Pharmaceuticals, Inc.

13/05/2024 Q1 2024 Earnings Release (Projected)
12/08/2024 Q2 2024 Earnings Release (Projected)
19/11/2024 Q3 2024 Earnings Release (Projected)
19/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Aridis Pharmaceuticals, Inc.

12/01/2024 17:00 Annual General Meeting
15/12/2023 17:00 Annual General Meeting
03/11/2023 20:15 Q3 2023 Earnings Release
08/06/2023 21:05 Q1 2023 Earnings Release
25/01/2023 21:15 Aridis Pharmaceuticals Corporate Update Conference Call
21/11/2022 23:30 Q3 2022 Earnings Release
16/08/2022 21:15 Interim 2022 Earnings Release
07/06/2022 16:00 Investor Meeting - Fireside Chat - M-Vest
02/06/2022 17:00 Annual General Meeting
16/05/2022 21:05 Q1 2022 Earnings Release
31/03/2022 23:04 FY 2021 Earnings Release
23/02/2022 17:30 Aegis Capital Virtual Summit
27/01/2022 21:15 Business Update Call
10/11/2021 13:00 Q3 2021 Earnings Release
26/09/2021 Cantor Fitzgerald Global Healthcare Conference
12/09/2021 H.C. Wainwright Global Investment Conference
12/08/2021 14:00 Interim 2021 Earnings Release
02/06/2021 Annual General Meeting
11/05/2021 21:01 Q1 2021 Earnings Release
30/03/2021 22:49 FY 2020 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		2,76
1,84
49.51%		1,02
1,89
-45.81%		1,00
1,50
-33.33%		1,54
2,43
-36.88%		3,09
2,19
40.91%
21,4

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-28,7
-29,3
1.88%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-24,1
-26,8
10.13%		-29,1
-30,6
4.92%		-22,4
-22,5
0.61%		-43,7
-40,8
-7.14%		-30,0
-30,7
2.19%
5,60

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-22,1
-24,5
9.92%		-29,7
-31,2
4.94%		-22,3
-22,5
0.53%		-43,2
-38,8
-11.27%		-30,4
-31,8
4.58%
4,30

Net income
Million USD		Released
Forecast
Spread 		-23,5
-25,9
9.3%		-29,7
-31,2
4.94%		-22,3
-22,5
0.53%		-47,3
-40,9
-15.79%		-30,4
-31,8
4.58%
4,30

EPS
USD		Released
Forecast
Spread 		-2,89
-5,51
47.48%		-3,51
-3,70
5.05%		-2,44
-2,44
0%		-3,85
-3,50
-10%		-1,62
-1,74
6.72%
0,07

Announcement Date28/03/1908/04/2030/03/2101/04/2222/05/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,52
0,30
71.67%		0,57
1,90
-70%		1,19
1,00
18.7%		0,29
10,5
-97.21%		0,40
7,47
-94.66%		1,21
0,31
293.41%





0,42
1,50
-72.2%
0,30

EBIT
Million USD		Released
Forecast
Spread 		-21,0
-7,44
-182.47%		-9,97
-6,75
-47.69%		-7,42
-9,00
17.51%		-7,74
1,21
-738.1%		-7,41
-1,13
-558.84%		-7,42
-8,12
8.58%





-0,87
-4,20
79.31%
-1,00

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-21,0
-7,30
-187.7%		-10,2
-5,43
-88.52%		-7,77
-9,00
13.71%		-7,98
0,96
-928.99%		-8,24
-1,21
-581.85%		-10,5
-8,11
-29.36%





-0,08
-4,20
98.02%
-1,00

Net income
Million USD		Released
Forecast
Spread 		-24,1
-7,30
-230.73%		-13,4
-5,43
-146.41%		-7,77
-9,00
13.71%		-7,98
-0,39
-1959.1%		-8,24
-8,71
5.43%		-10,5
-8,11
-29.36%


12,1


-0,08
-4,20
98.02%
-1,00

EPS
USD		Released
Forecast
Spread 		-1,94
-0,50
-288%		-0,92
-0,33
-183.08%		-0,44
-0,51
13.73%		-0,45
-0,06
-650%		-0,47
-0,17
-176.47%		-0,50
-0,41
-21.95%		-0,22


0,33


0,00
-0,10
-
-0,02

Announcement Date10/11/2101/04/2216/05/2216/08/2221/11/2222/05/2309/06/2314/09/2303/11/23-

Upcoming sector events for Aridis Pharmaceuticals, Inc.

Today 11:00 AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release
Today 11:30 SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today 11:30 REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today 12:00 AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today 16:00 GENMAB A/S: Q1 2024 Earnings Release
Today 21:01 ASCENDIS PHARMA A/S: Q1 2024 Earnings Release
05/05/2024 FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected)
05/05/2024 KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release
05/05/2024 MERUS N.V.: Q1 2024 Earnings Release (Projected)
05/05/2024 VAXCYTE, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Aridis Pharmaceuticals, Inc.

Today ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
Today DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
Today GERON CORPORATION: Q1 2024 Earnings Release
Today KURA ONCOLOGY, INC.: Q1 2024 Earnings Release
Today KEROS THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today ALECTOR, INC.: Q1 2024 Earnings Release (Projected)
Today ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release
Today TRAVERE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today ARDELYX, INC.: Q1 2024 Earnings Release
Today ZYMEWORKS INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ARDS Stock
  4. Calendar Aridis Pharmaceuticals, Inc.